SCHEMBL10694809

SCHEMBL10694809

CC([C]=O)N(C)Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2B P18089 2/20 0.61
ADRA2C P18825 2/20 0.61
ADRA1A P35348 2/20 0.61
OPRK1 P41145 2/20 0.61
SLC6A2 P23975 1/20 0.61
HTR2A P28223 1/20 0.61
SLC6A4 P31645 1/20 0.61
SLC6A3 Q01959 1/20 0.61
KCNH2 Q12809 1/20 0.61
HPGD P15428 1/20 0.49
TSHR P16473 3/20 0.48
ALDH1A1 P00352 1/20 0.48
MAOB P27338 6/20 0.46
MAOA P21397 4/20 0.46
CYP1A2 P05177 2/20 0.46
PYCR1 P32322 1/20 0.46
ADRA2A P08913 1/20 0.46
SNCA P37840 1/20 0.46
CYP2D6 P10635 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9470009 0.81 ADRA2B (0.53) ADRA2BADRA2CADRA1AOPRK1SLC6A2
SCHEMBL9470010 0.81 ADRA2B (0.53) ADRA2BADRA2CADRA1AOPRK1SLC6A2
SCHEMBL29424302 0.81 PYCR1 (0.69) ADRA2BADRA2CADRA1AOPRK1SLC6A2
SCHEMBL9470042 0.79 KMT2A (0.54) ADRA2BADRA2CADRA1AOPRK1SLC6A2
SCHEMBL9470037 0.79 KMT2A (0.54) ADRA2BADRA2CADRA1AOPRK1SLC6A2
SCHEMBL10721571 0.78 SLC6A2 (0.68) ADRA2BADRA2CADRA1AOPRK1SLC6A2
SCHEMBL530326 0.77 ADRA2B (0.67) ADRA2BADRA2CADRA1AOPRK1SLC6A2
SCHEMBL10768255 0.77 ADRA2B (0.51) ADRA2BADRA2CADRA1AOPRK1SLC6A2
Benzphetamine SCHEMBL19285634 0.76 ADRA2B (1.00) ADRA2BADRA2CADRA1AOPRK1SLC6A2
Hydrochloric Acid SCHEMBL9125055 0.76 ADRA2B (0.66) ADRA2BADRA2CADRA1AOPRK1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252482-A2 7-Acyloxy-6-aminoacyloxypolyoxylabdanes, process for their preparation and their use as medicine HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-13 EP disclosed
EP-0217372-A2 Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-08 EP disclosed